Updated:
Amsino International
Richard Y. Lee founded vertically integrated medical-device manufacturer Amsino International in 1993, supplying U.S.
Amsino International
Amsino International was established in 1993 by Richard Y. Lee, who positioned the firm as a manufacturer of disposable medical devices with an emphasis on infection control and fluid management. The company is headquartered in Pomona, California, and manufactures products through its subsidiary in Shanghai, China, giving it a direct operational footprint across the two largest healthcare markets in the world. Its core competency lies in products such as closed-suction catheters, urine meters, and enteral feeding bags — unglamorous but essential hospital consumables. The company's strategy centers on vertical integration from manufacturing to distribution, with a product catalog that also includes IV sets, extension sets, and blood-pressure monitoring kits. Amsino supplies acute-care hospitals and alternate-site facilities, competing against larger players like Becton Dickinson and Cardinal Health's private-label divisions. Rather than chasing novel MedTech innovations, the firm deploys capital into production efficiency and regulatory compliance, maintaining FDA 510(k) clearances and ISO 13485 certification across its manufacturing lines. Its geographic reach covers North America, Asia, and select European markets through a network of distributors. Amsino operates its primary manufacturing campus in Shanghai, while corporate strategy, logistics, and U.S. sales run from its Pomona headquarters. The firm has not publicly disclosed its total deployment or workforce size. It remains a privately held company owned by Lee, without disclosed venture-capital backing or private-equity sponsorship, which distinguishes it from the roll-up heavy MedTech middle market. Adjacent business units or philanthropic structures have not been disclosed. What structurally separates Amsino from the typical U.S. medical-supply distributor is the depth of its in-house Chinese manufacturing capabilities. Most competitors source from contract manufacturers; Amsino's model gives it a direct line from factory floor to hospital loading dock. This architecture creates a genuine margin moat in commoditized device categories where competitors must absorb middlemen costs.
General information
Firm type
Asset Manager
Year founded
1993
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Pomona
Corporate office
Pomona, CA, United States
Principals
Richard Y. Lee
Founder & CEO
Sector focus
Frequently asked questions
Where does Amsino International manufacture its products?
Amsino manufactures its products through its own subsidiary in Shanghai, China. The firm operates a dedicated production campus there, which allows it to directly control manufacturing quality, supply chain logistics, and production costs. This direct ownership of manufacturing is a core structural feature of the company, distinguishing it from distributors that rely on third-party contract manufacturers.
What specific medical devices does Amsino produce?
Amsino's product catalog focuses on disposable, single-use medical devices used primarily in hospital settings. Its best-known products include closed-suction catheters, urine meters, enteral feeding bags, IV administration sets, and blood-pressure monitoring kits. These are consumables used daily in acute and post-acute care, where infection control and supply reliability are critical.
How does Amsino's business model differ from larger competitors like Becton Dickinson?
The primary structural difference is vertical integration. Large diversified conglomerates often use a mix of in-house manufacturing and contract sourcing. Amsino, by contrast, operates its own factory in Shanghai, controlling production from raw materials to finished goods for a narrower set of commodity medical consumables. This allows it to compete on price in high-volume product categories where larger rivals carry higher overhead.
Is Amsino International a family office or an operating company?
Amsino International is an operating company, not a family office. It designs, manufactures, and sells medical devices to hospitals and healthcare facilities. It has not publicly disclosed any separate family-office function for managing its founder's wealth, nor does it appear to operate as an investment holding company with a diversified portfolio of financial assets.
How is Amsino regulated as a medical-device manufacturer?
Amsino holds FDA 510(k) clearances for its medical devices sold in the United States, signifying that its products are substantially equivalent to predicate devices already on the market. Its Shanghai manufacturing facility also maintains ISO 13485 certification, the international standard for quality management systems specific to medical devices. These certifications are essential for selling into U.S. hospital systems.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: